Inventor · disambiguated record
Jean-Pierre Sommadossi
Also filed as: SOMMADOSSI JEAN-PIERRE
82 granted patents·35 pending applications·4,316 citations·filing 1988–2025
99Inventor score
Files withATEA PHARMACEUTICALS INC36IDENIX PHARMACEUTICALS INC31UNIV CAGLIARI10IDENIX PHARMACEUTICALS LLC7UNIV EMORY6
Top patents by PatentIndex Score
117 records- 0199US7608600B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Oct 27, 2009·181 cites·85 claims
- 0299US7608597B2Methods and compositions for treating hepatitis C virusIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Oct 27, 2009·184 cites·33 claims
- 0399US7365057B2Modified 2′ and 3′-nucleoside prodrugs for treating Flavivridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Apr 29, 2008·118 cites·52 claims
- 0499US6914054B2Methods and compositions for treating hepatitis C virusIDENIX PHARMACEUTICALS INC·Filed 2001·Granted Jul 5, 2005·252 cites·27 claims
- 0599US6812219B2Methods and compositions for treating flaviviruses and pestivirusesIDENIX PHARMACEUTICALS INC·Filed 2001·Granted Nov 2, 2004·211 cites·32 claims
- 0698US11738038B2Highly active compounds against COVID-19ATEA PHARMACEUTICALS INC·Filed 2021·Granted Aug 29, 2023·4 cites·38 claims
- 0798US10894804B2Nucleotide hemi-sulfate salt for the treatment of hepatitis C virusATEA PHARMACEUTICALS INC·Filed 2020·Granted Jan 19, 2021·10 cites·37 claims
- 0898US10875885B2β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n6-substituted purine nucleotides for HCV treatmentATEA PHARMACEUTICALS INC·Filed 2020·Granted Dec 29, 2020·9 cites·24 claims
- 0998US10874687B1Highly active compounds against COVID-19ATEA PHARMACEUTICALS INC·Filed 2020·Granted Dec 29, 2020·34 cites·20 claims
- 1098US10870672B2β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatmentATEA PHARMACEUTICALS INC·Filed 2020·Granted Dec 22, 2020·9 cites·36 claims
- 1198US10870673B2β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatmentATEA PHARMACEUTICALS INC·Filed 2020·Granted Dec 22, 2020·9 cites·34 claims
- 1298US10815266B2β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatmentATEA PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·10 cites·2 claims
- 1398US10519186B2Nucleotide hemi-sulfate salt for the treatment of hepatitis C virusATEA PHARMACEUTICALS INC·Filed 2018·Granted Dec 31, 2019·24 cites·52 claims
- 1498US9828410B2β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatmentATEA PHARMACEUTICALS INC·Filed 2016·Granted Nov 28, 2017·28 cites·3 claims
- 1598US8343937B2Methods and compositions for treating flaviviruses and pestivirusesIDENIX PHARMACEUTICALS INC·Filed 2006·Granted Jan 1, 2013·52 cites·10 claims
- 1698US7635689B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Dec 22, 2009·120 cites·29 claims
- 1798US7582618B22′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2006·Granted Sep 1, 2009·81 cites·36 claims
- 1898US7547704B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Jun 16, 2009·84 cites·40 claims
- 1998US7169766B2Methods and compositions for treating hepatitis C virusUNIV CAGLIARI·Filed 2003·Granted Jan 30, 2007·148 cites·55 claims
- 2098US7163929B2Methods and compositions for treating flaviviruses and pestivirusesUNIV CAGLIARI·Filed 2003·Granted Jan 16, 2007·173 cites·31 claims
- 2198US7157441B2Methods and compositions for treating hepatitis C virusUNIV CAGLIARI·Filed 2003·Granted Jan 2, 2007·152 cites·39 claims
- 2298US7148206B2Methods and compositions for treating flaviviruses and pestivirusesUNIV CAGLIARI·Filed 2003·Granted Dec 12, 2006·166 cites·42 claims
- 2398US7105493B2Methods and compositions for treating flaviviruses and pestivirusesUNIV CAGLIARI·Filed 2003·Granted Sep 12, 2006·225 cites·18 claims
- 2497US12006340B2Nucleotide hemi-sulfate salt for the treatment of hepatitis c virusATEA PHARMACEUTICALS INC·Filed 2023·Granted Jun 11, 2024·2 cites·15 claims
- 2597US11813278B2Highly active compounds against COVID-19ATEA PHARMACEUTICALS INC·Filed 2021·Granted Nov 14, 2023·3 cites·37 claims
- 2697US11707480B2Highly active compounds against COVID-19ATEA PHARMACEUTICALS INC·Filed 2020·Granted Jul 25, 2023·3 cites·8 claims
- 2797US10239911B2Beta-D-2′-deoxy-2′-alpha-fluoro-2′-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatmentATEA PHARMACEUTICALS INC·Filed 2018·Granted Mar 26, 2019·18 cites·24 claims
- 2897US10005811B2β-D-2′-deoxy-2′-α-fluoro-2′β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatmentATEA PHARMACEUTICALS INC·Filed 2017·Granted Jun 26, 2018·19 cites·22 claims
- 2997US10000523B2β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatmentATEA PHARMACEUTICALS INC·Filed 2017·Granted Jun 19, 2018·20 cites·30 claims
- 3097US8637475B1Modified 2′ and 3′ nucleoside prodrugs for treating flaviviridae infectionsSTORER RICHARD·Filed 2011·Granted Jan 28, 2014·68 cites·11 claims
- 3197US8299038B2Methods and compositions for treating hepatitis C virusSOMMADOSSI JEAN-PIERRE·Filed 2009·Granted Oct 30, 2012·71 cites·15 claims
- 3297US7951789B2Compounds and pharmaceutical compositions for the treatment of viral infectionsIDENIX PHARMACEUTICALS INC·Filed 2007·Granted May 31, 2011·92 cites·10 claims
- 3397US7902202B2Compounds and pharmaceutical compositions for the treatment of viral infectionsIDENIX PHARMACEUTICALS INC·Filed 2008·Granted Mar 8, 2011·80 cites·29 claims
- 3497US7625875B22′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Dec 1, 2009·86 cites·44 claims
- 3597US7384924B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Jun 10, 2008·77 cites·46 claims
- 3697US7192936B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsUNIV CAGLIARI·Filed 2004·Granted Mar 20, 2007·84 cites·48 claims
- 3797US7101861B2Methods and compositions for treating flaviviruses and pestivirusesUNIV CAGLIARI·Filed 2003·Granted Sep 5, 2006·78 cites·45 claims
- 3897US6787526B1Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2002·Granted Sep 7, 2004·93 cites·25 claims
- 3996US12226429B2Highly active compounds against COVID-19ATEA PHARMACEUTICALS INC·Filed 2023·Granted Feb 18, 2025·1 cites·17 claims
- 4096US12084473B2β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatmentATEA PHARMACEUTICALS INC·Filed 2023·Granted Sep 10, 2024·1 cites·29 claims
- 4196US10906928B2Nucleotide hemi-sulfate salt for the treatment of hepatitis C virusATEA PHARMACEUTICALS INC·Filed 2019·Granted Feb 2, 2021·10 cites·34 claims
- 4296US8691788B2Compounds and pharmaceutical compositions for the treatment of viral infectionsSOMMADOSSI JEAN-PIERRE·Filed 2011·Granted Apr 8, 2014·62 cites·21 claims
- 4396US7662798B22′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Feb 16, 2010·77 cites·20 claims
- 4496US7456155B22′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Nov 25, 2008·88 cites·39 claims
- 4595US12134588B2Crystalline epinephrine malonate saltBIOTHEA PHARMA INC·Filed 2022·Granted Nov 5, 2024·3 cites·20 claims
- 4695US11975016B22′-substituted-N6-substituted purine nucleotides for RNA virus treatmentATEA PHARMACEUTICALS INC·Filed 2021·Granted May 7, 2024·2 cites·26 claims
- 4795US7138376B2Methods and compositions for treating hepatitis C virus using 4'-modified nucleosidesCENTRE NAT RECH SCIENT·Filed 2002·Granted Nov 21, 2006·81 cites·31 claims
- 4895US6596700B2Methods of treating hepatitis delta virus infection with β-L-2'-deoxy-nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2001·Granted Jul 22, 2003·61 cites·57 claims
- 4994US5077280ATreatment of viral infectionsUNIV BROWN RES FOUND·Filed 1988·Granted Dec 31, 1991·45 cites·26 claims
- 5093US10946033B22′-substituted-N6-substituted purine nucleotides for RNA virus treatmentATEA PHARMACEUTICALS INC·Filed 2019·Granted Mar 16, 2021·6 cites·23 claims
Showing the top 50 of 117 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jean-Pierre Sommadossi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →